Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2010

View Archived Issues

AGN-203818 useful to reduce hypersensitivity in heartburn and IBS patients

Acute rejection rates similar with CP-690550 and ciclosporin in renal transplant patients

Pfizer identifies new fatty-acid amide hydrolase inhibitors

Ranolazine exhibits antifibrillatory activity during severe coronary stenosis

Phase II data in cystic fibrosis disclosed on TR-02

Clinical safety and pharmacokinetic data of inhaled liposomal ciprofloxacin reported

Comparable safety/efficacy/tolerability of ilaprazole and esomeprazole in duodenal ulcer

Increased IGFBP-7 expression reduces breast cancer growth

Lundbeck reports highlights of first quarter 2010

NeuroTherapeutics closes series B financing to advance pipeline

Vagifem 10-mcg tablets replace 25-mcg formulation for atrophic vaginitis

Anadys reports on phase II combination trial of ANA-598

AndroScience and Orient Europharma collaborate on topical acne therapy

Bayer Schering Pharma claims new MEK 1 inhibitors

Janssen describes new serotonin receptor ligands

Ligand acquires milestone and royalty interest in MEDI-528 for asthma

New mGlu5 receptor antagonists claimed by GlaxoSmithKline

Sorrento Therapeutics receives NIH grant for innovative MRSA infection program

Grifols acquires Pharmalink's post-polio syndrome drug development project

NORD awards Shire for developing VPRIV in Gaucher's disease

Elagolix meets all efficacy endpoints in phase II trial in endometriosis

FDA extends review period of FTY-720 in relapsing MS

New data on coadministration of Intuniv and stimulants in ADHD

Enrollment complete in phase II brentuximab vedotin trial in ALCL

Phase III data reported on clobazam in Lennox-Gastaut syndrome

Intercell honored for developing IC-51 Japanese encephalitis vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...